What to Do When Marketing Is Working But Revenue Isn’t Growing

You've seen the monthly report. Leads are up. Cost per lead is down. Your marketing director is presenting numbers that, on paper, look like everything is working. And yet — when you look at the firm's actual revenue trajectory, something doesn't add up. Growth has stalled, or it's not keeping pace with spend.

This is one of the most disorienting experiences a managing partner can have. The data says things are improving. Your gut says they're not. And you don't have the language to explain why the two don't match.

Here's what's usually happening: the metrics your team is reporting are accurate — but they're measured at the wrong depth. They're surface-level indicators that can all trend positive while the underlying economics of your marketing investment are deteriorating. This isn't a people problem. It's a data depth problem. And it shows up in three very specific ways.

The Three “Marketing Is Working” Illusions

When PI firms hit this disconnect — positive KPIs but flat or declining revenue — it's almost never one thing. These three illusions tend to appear simultaneously, and they reinforce each other in ways that make the problem harder to diagnose.

Illusion One: Lead Volume Is Up, but Conversion Is Down

Your marketing team reports that leads increased from 400 to 520 per month. That's a 30% increase. The chart goes up and to the right. Everyone feels good.

But when you look at signed cases, the number hasn't moved — or it's barely budged. You signed 48 cases last quarter and 51 this quarter. That's not a 30% increase. That's noise.

What happened? The additional leads came from sources with lower conversion rates. Maybe a new vendor was added that delivers high volume but poor-quality leads. Maybe an existing vendor shifted their targeting to hit a volume commitment. The lead count went up, but the percentage that converted to signed cases went down — and nobody flagged it because nobody was tracking conversion rate by source.

A firm spending $350,000 per month on marketing that adds 120 leads but only 3 additional signed cases has effectively paid $40,000 per incremental case — even if the blended cost per lead looks favorable.

Illusion Two: Cost Per Lead Is Down, but Cost Per Case Is Up

This one is subtler and more common than most firms realize. Cost per lead is the metric that vendors love to report, because it almost always looks good. A vendor can reduce CPL by broadening targeting, loosening qualification criteria, or simply counting more interactions as “leads.”

Your marketing director sees CPL drop from $180 to $145 and reports it as a win. And it looks like one — at that layer. But if those cheaper leads convert at half the rate, your cost per signed case actually increased. You're paying less per lead and more per case. The metric that matters to your P&L — cost per case — moved in the wrong direction.

This illusion persists because most firms don't calculate cost per case by vendor. They calculate a blended average, if they calculate it at all. So a single vendor driving up cost per case gets averaged into the portfolio, and the deterioration happens slowly enough that nobody notices for months.

Illusion Three: Signed Cases Are Up, but Settlement Values Are Declining

This is the deepest illusion, and it takes the longest to surface — sometimes 12 to 18 months, given the settlement timeline in personal injury. Your firm signed more cases this year than last year. That feels like growth. But when those cases begin settling, the average settlement value per case is lower than your historical baseline.

Why? Because the lead sources that drove volume growth are producing lower-severity cases. More fender benders, fewer surgeries. More soft tissue, fewer catastrophic injuries. The signed case count went up, but the revenue per case went down — and you won't see it in the data until settlements come in.

A firm that signs 20% more cases but at 30% lower average settlement value has actually shrunk its revenue pipeline. The marketing team celebrated. The P&L didn't.

Why These Illusions Persist

The structural reason these illusions survive is that most PI firms measure marketing performance at the top of the funnel — leads and cost per lead — without connecting those metrics to what happens downstream. Lead volume, cost per lead, and even signed case count are all proxy metrics. They're useful as leading indicators, but they can all move in a positive direction while the actual return on marketing investment declines.

Think of it as measuring altitude without measuring speed. You can be high up and still falling. The altimeter reads fine right now, but the trajectory is wrong.

The deeper problem is that the metrics needed to see through these illusions — cost per signed case by vendor, conversion rate by source, average settlement value by lead origin — live in different systems. Lead data is in one place. Spend data is in another. Case outcomes are in a third. And settlement figures are in a fourth. No single report connects them, so nobody has the full picture.

This isn't a failure of effort or intelligence. It's a structural gap in how most PI firms have assembled their data. Marketing reports from the marketing layer. Intake reports from the intake layer. Finance reports from the finance layer. The illusions live in the spaces between those layers.

How to Diagnose Which Illusion You're Seeing

If you suspect your firm is experiencing this disconnect, there are three diagnostic questions you can answer — even with imperfect data — to identify which illusion is at play.

• Is lead-to-signed-case conversion rate holding steady, or declining? Pull lead count and signed case count for the last six months. Calculate the ratio each month. If leads are up but the conversion percentage is dropping, you're seeing Illusion One. Look at conversion rate by vendor to identify which sources are dragging it down.
• Is your cost per signed case rising even as cost per lead falls? Take total marketing spend for the quarter and divide by signed cases. Compare to the previous quarter. If cost per case is rising while CPL is falling, you're seeing Illusion Two. The fix requires calculating cost per case at the vendor level, not just in aggregate.
• Is your average case value changing as your case mix shifts? If you have severity data — even rough categories like soft tissue vs. surgery vs. catastrophic — look at whether the proportion of higher-value cases is declining. If your signed case volume is up but your severity mix is shifting toward lower-value cases, you're seeing Illusion Three. This one takes the longest to confirm because settlement data lags.

Most firms experiencing stalled revenue growth despite positive marketing KPIs will find that two or three of these illusions are present at the same time. That's not a coincidence — they share a common root cause.

What the Fix Looks Like

The solution isn't to discard cost per lead or lead volume as metrics. They're still useful signals. The fix is to connect them to what happens downstream — so that every surface-level metric has a deeper metric anchoring it to reality.

• Lead volume should be paired with conversion rate by source
• Cost per lead should be paired with cost per signed case by vendor
• Signed case count should be paired with projected settlement value by lead origin

When these connections exist, the illusions dissolve. You can see immediately when a vendor is delivering high volume at low conversion. You can see when cheap leads are actually expensive cases. You can see when case volume growth is masking declining case quality.

This is what connected marketing attribution looks like in practice: not more data, but data measured at the right depth. Lead to signed case to settlement, tracked by source, with cost attached at every stage.

Building this view doesn't require hiring a data analyst or spending months on a custom dashboard. It requires connecting the data that already exists in your intake system, case management software, and vendor invoices into a single, continuous thread. For firms using LeadDocket, that connection can be established quickly through native integration. For others, it's a matter of standardizing the data pipeline from lead source to case outcome.

The Conversation That Needs to Happen

If you're a managing partner who has felt this disconnect — the reports say one thing, the bank account says another — you're not wrong to trust your instinct. But the productive next step isn't to question whether your marketing director is doing a good job. In most cases, they are. They're optimizing the metrics they can see.

The productive conversation sounds like this: “I can see that lead volume and cost per lead are trending well. What I need to understand is whether cost per signed case is moving in the same direction — and whether the cases we're signing are maintaining their value. Can we build a view that connects our marketing spend to case outcomes by vendor?”

That's not an accusation. It's a structural request. And for most marketing directors, it's a relief — because they've felt the same gap. They know that the metrics they report don't tell the full story. They just haven't had the tools or the mandate to build the deeper view.

The firms that break through this plateau are the ones where the managing partner and the marketing director agree on what “working” actually means — and it's not lead volume. It's cost per case trending down, case quality holding steady, and revenue growing in proportion to spend.

If you want a framework for how that managing partner review should be structured, it starts with the three metrics above: cost per case by vendor, conversion rate by source, and settlement value by lead origin. When those three numbers are on the table, the conversation moves from “is marketing working?” to “which parts of marketing are working, and where should we reallocate?”

That's the conversation that drives growth. And it only becomes possible when you measure marketing at the right depth.